OpenAI absorbs Orchestra Bio to bulk up Rosalind

OpenAI announced the acquisition of Orchestra Bio on Tuesday. The deal brings Orchestra's team and its proprietary technology into the Rosalind ecosystem, the company's AI model aimed at life‑science research. OpenAI …

Rosalind already supports protein‑folding predictions and small‑molecule design. Orchestra Bio's expertise lies in automating assay design and data‑capture pipelines. By merging the two, OpenAI hopes to shorten the it…

PIN‑protected chats arrive for ChatGPT users